Amedisys Inc/ US0234361089 /
11/10/2024 16:38:09 | Chg. -0.0239 | Volume | Bid11/10/2024 | Ask11/10/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
96.5461USD | -0.02% | 6,538 Turnover: 327,886.7350 |
96.5400Bid Size: 300 | 96.6000Ask Size: 100 | 3.16 bill.USD | - | - |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 159 | 137.4550 | 42.6950 | 36.9990 | 31.1000 | ||||||
Intangible Assets | 36.7000 | 33.1930 | 44.0470 | 46.7550 | 46.0610 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 534.1840 | 509.8220 | 519.1190 | 502.3260 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 111.1000 | 99.3250 | 125.0100 | 166.0560 | 201.1960 | ||||||
Cash and Cash Equivalents | 17.3000 | 8.0320 | 27.5020 | 30.1970 | 86.3630 | ||||||
Current Assets | 205.3000 | 135.5580 | 175.2630 | 214.9100 | 311.1560 | ||||||
Total Assets | 726.4000 | 669.7420 | 685.0850 | 734.0290 | 813.4820 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 20.1000 | 16.0560 | 25.6820 | 30.3580 | 25.3840 | ||||||
Long-term debt | 33 | 104.3720 | 95 | 87.8090 | 78.2000 | ||||||
Liabilities to Banks | 46.9000 | 116.4000 | 100 | 93 | 88.8000 | ||||||
Provisions | - | 2.4000 | - | - | - | ||||||
Liabilities | 353.9000 | 271.9800 | 274.6490 | 272.8870 | 297.0560 | ||||||
Share Capital | .0300 | .0350 | .0350 | .0350 | .0350 | ||||||
Total Equity | 372.5000 | 397.7620 | 410.4360 | 461.1420 | 516.4260 | ||||||
Minority Interests | .3000 | .5950 | .8680 | .9390 | 1.1050 | ||||||
Total liabilities equity | 726.4000 | 669.7420 | 685.0850 | 734.0290 | 813.4820 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,249.3000 | 1,204.5540 | 1,280.5410 | 1,437.4540 | 1,533.7000 | ||||||
Depreciation (total) | 36.9000 | 28.3470 | 20.0360 | - | - | ||||||
Operating Result | -155 | 24.0470 | -9.1660 | 57.3400 | 78.5240 | ||||||
Interest Income | -4.3500 | -8.1230 | -10.7120 | -5.0890 | -4.8730 | ||||||
Income Before Taxes | -153.5000 | 20.9760 | -.3080 | 61.5660 | 80.8010 | ||||||
Income Taxes | -58.8000 | -7.6710 | -2.0040 | -23.9350 | -50.1000 | ||||||
Minority Interests Profit | 1.6000 | -.3130 | -.7090 | -.3700 | -.3820 | ||||||
Net Income | -96.2000 | 12.7760 | -3.0210 | 37.2610 | 30.3000 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 102.3000 | -65.5340 | 107.7850 | 62.2590 | 105.7310 | ||||||
Cash Flow from Investing Activities | -46.5000 | -14.3000 | -67.4210 | -52.0490 | -44.0270 | ||||||
Cash Flow from Financing | -53 | 70.5630 | -20.8940 | -7.5150 | -5.5380 | ||||||
Decrease / Increase in Cash | 2.8000 | -9.2710 | 19.4700 | 2.6950 | 56.1660 | ||||||
Employees | 14,300 | 13,200 | 16,100 | 16,000 | 17,900 |